Model Number 3CX*FX25RWC |
Device Problem
Gas Output Problem (1266)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 11/12/2021 |
Event Type
malfunction
|
Manufacturer Narrative
|
Terumo has not received the device for evaluation; therefore, the investigation has yet to be completed.Terumo plans on submitting a follow-up report when the investigation is complete and when more information becomes available.(b)(4).
|
|
Event Description
|
The user facility reported to terumo cardiovascular that during cardiopulmonary bypass, they noticed the po2 level dropped down drastically to 68.As per subsidiary, "one hour after cardiopulmonary bypass started the po2 level dropped down drastically to 68.Perfusionist increased the mixer setting to %100 oxygen but the po2 level in patients blood didn¿t increase.Perfusionist check the oxygen supply and the mixer, oxygen supply was working and to be sure she changed the mixer with another one but po2 level didn¿t increase.She changed the oxygenator with a new one and po2 level of the patient blood increased to 338 with %40 oxygen from the mixer." *no known impact or consequence to patient , *product was changed out, *procedure was completed successfully.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations ¿ and as indicated by terumo cardiovascular systems in the initial report submitted to the fda on december 3, 2021.Upon further investigation of the reported event, the following information is new and/or changed: g6 (indication that this is a follow-up report).H2 (follow-up due to additional information).H3 (device evaluation anticipated by manufacturer - a second follow-up will be submitted upon completion of the investigation and/or submission of new information, thus tcvs references conclusions code 11.).All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Manufacturer Narrative
|
This follow-up report is submitted to fda in accord with applicable regulations.Upon further investigation of the reported event, the following information is new and/or changed: d4 (additional device information - added exp date).G3 (date received by manufacturer).G6 (indication that this is a follow-up report).H2 (follow-up due to additional information and device evaluation).H3 (device evaluated by manufacturer).H6 (identification of evaluation codes 10, 3331, 213, 4315).Type of investigation #1: 11 - testing of device from same lot/batch retained by manufacturer.Type of investigation #2: 3331 - analysis of production records.Investigation findings: 213 - no device problem found.Investigation conclusions: 4315 - cause not established.Based on the investigation result, no anomaly was found in the gas transfer performance of the actual sample after rinsing and in the manufacturing record.As the event could not be replicated, a definitive root cause cannot be determined for this event.All available information has been placed on file in quality management for appropriate tracking, trending, and follow-up.
|
|
Search Alerts/Recalls
|
|